Health
ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa – News-Medical.Net
The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide,…
The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe.
The ANTICOV study is being carried out by a consortium of 26 partners which include leading African research institutions and international health organizations, coordinated by the non-profit research and development (R&D) organization Drugs for Neglected…
-
Noosa News23 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General18 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General17 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues
-
General23 hours agoEaster drowning toll in NSW rises after fisherman swept off rocks in Sydney’s south